APO Research
Talk to an analyst

APO RESEARCH · REPORT

Decitabine Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Decitabine Drug Market Analysis and Forecast 2026-2032

22 December 2025190 pages

Choose your research edition.

Industry ResearchDecitabine Drug Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Decitabine Drug Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Decitabine Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Decitabine Drug Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Decitabine Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Decitabine Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Decitabine Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Decitabine Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Decitabine Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Decitabine Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Decitabine Drug include Sun Pharmaceutical, Sandoz, Otsuka Pharmaceutical, Lupin, Dr Reddy's Laboratories, Cipla and Accord Healthcare, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Decitabine Drug, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Decitabine Drug, also provides the revenue of main regions and countries. Of the upcoming market potential for Decitabine Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Decitabine Drug revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Decitabine Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Decitabine Drug revenue, projected growth trends, production technology, application and end-user industry.

Decitabine Drug Segment by Company

Sun Pharmaceutical

Sandoz

Otsuka Pharmaceutical

Lupin

Dr Reddy's Laboratories

Cipla

Accord Healthcare

Decitabine Drug Segment by Type

Dacogen

Generic

Decitabine Drug Segment by Application

Hospital

Drug store

Decitabine Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Decitabine Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Decitabine Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Decitabine Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Decitabine Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Decitabine Drug company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Decitabine Drug revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Decitabine Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Dacogen Major Player Table 3. Generic Major Player Table 4. Global Decitabine Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Drug store Major Player Table 7. Decitabine Drug Industry Trends Table 8. Decitabine Drug Industry Drivers Table 9. Decitabine Drug Industry Opportunities and Challenges Table 10. Decitabine Drug Industry Restraints Table 11. Global Decitabine Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Decitabine Drug Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Decitabine Drug Market Share by Region (2021-2026) Table 14. Global Decitabine Drug Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Decitabine Drug Market Share by Region (2027-2032) Table 16. Global Decitabine Drug Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Decitabine Drug Revenue Market Share by Players (2021-2026) Table 18. Global Decitabine Drug Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Decitabine Drug Key Players Headquarters & Area Served Table 20. Global Decitabine Drug Players, Product Type & Application Table 21. Global Decitabine Drug Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Decitabine Drug by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Decitabine Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Decitabine Drug Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Decitabine Drug Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Decitabine Drug Revenue Market Share by Type (2021-2026) Table 28. Global Decitabine Drug Revenue Market Share by Type (2027-2032) Table 29. Global Decitabine Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Decitabine Drug Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Decitabine Drug Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Decitabine Drug Revenue Market Share by Application (2021-2026) Table 33. Global Decitabine Drug Revenue Market Share by Application (2027-2032) Table 34. Sun Pharmaceutical Company Information Table 35. Sun Pharmaceutical Business Overview Table 36. Sun Pharmaceutical Decitabine Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Sun Pharmaceutical Decitabine Drug Product Portfolio Table 38. Sun Pharmaceutical Recent Development Table 39. Sandoz Company Information Table 40. Sandoz Business Overview Table 41. Sandoz Decitabine Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Sandoz Decitabine Drug Product Portfolio Table 43. Sandoz Recent Development Table 44. Otsuka Pharmaceutical Company Information Table 45. Otsuka Pharmaceutical Business Overview Table 46. Otsuka Pharmaceutical Decitabine Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Otsuka Pharmaceutical Decitabine Drug Product Portfolio Table 48. Otsuka Pharmaceutical Recent Development Table 49. Lupin Company Information Table 50. Lupin Business Overview Table 51. Lupin Decitabine Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Lupin Decitabine Drug Product Portfolio Table 53. Lupin Recent Development Table 54. Dr Reddy's Laboratories Company Information Table 55. Dr Reddy's Laboratories Business Overview Table 56. Dr Reddy's Laboratories Decitabine Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Dr Reddy's Laboratories Decitabine Drug Product Portfolio Table 58. Dr Reddy's Laboratories Recent Development Table 59. Cipla Company Information Table 60. Cipla Business Overview Table 61. Cipla Decitabine Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Cipla Decitabine Drug Product Portfolio Table 63. Cipla Recent Development Table 64. Accord Healthcare Company Information Table 65. Accord Healthcare Business Overview Table 66. Accord Healthcare Decitabine Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Accord Healthcare Decitabine Drug Product Portfolio Table 68. Accord Healthcare Recent Development Table 69. North America Decitabine Drug Revenue by Type (2021-2026) & (US$ Million) Table 70. North America Decitabine Drug Revenue by Type (2027-2032) & (US$ Million) Table 71. North America Decitabine Drug Revenue by Application (2021-2026) & (US$ Million) Table 72. North America Decitabine Drug Revenue by Application (2027-2032) & (US$ Million) Table 73. North America Decitabine Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 74. North America Decitabine Drug Revenue by Country (2021-2026) & (US$ Million) Table 75. North America Decitabine Drug Revenue by Country (US$ Million) & (2027-2032) Table 76. Europe Decitabine Drug Revenue by Type (2021-2026) & (US$ Million) Table 77. Europe Decitabine Drug Revenue by Type (2027-2032) & (US$ Million) Table 78. Europe Decitabine Drug Revenue by Application (2021-2026) & (US$ Million) Table 79. Europe Decitabine Drug Revenue by Application (2027-2032) & (US$ Million) Table 80. Europe Decitabine Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 81. Europe Decitabine Drug Revenue by Country (2021-2026) & (US$ Million) Table 82. Europe Decitabine Drug Revenue by Country (US$ Million) & (2027-2032) Table 83. China Decitabine Drug Revenue by Type (2021-2026) & (US$ Million) Table 84. China Decitabine Drug Revenue by Type (2027-2032) & (US$ Million) Table 85. China Decitabine Drug Revenue by Application (2021-2026) & (US$ Million) Table 86. China Decitabine Drug Revenue by Application (2027-2032) & (US$ Million) Table 87. Asia Decitabine Drug Revenue by Type (2021-2026) & (US$ Million) Table 88. Asia Decitabine Drug Revenue by Type (2027-2032) & (US$ Million) Table 89. Asia Decitabine Drug Revenue by Application (2021-2026) & (US$ Million) Table 90. Asia Decitabine Drug Revenue by Application (2027-2032) & (US$ Million) Table 91. Asia Decitabine Drug Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 92. Asia Decitabine Drug Revenue by Region (US$ Million) & (2021-2026) Table 93. Asia Decitabine Drug Revenue by Region (US$ Million) & (2027-2032) Table 94. SAMEA Decitabine Drug Revenue by Type (2021-2026) & (US$ Million) Table 95. SAMEA Decitabine Drug Revenue by Type (2027-2032) & (US$ Million) Table 96. SAMEA Decitabine Drug Revenue by Application (2021-2026) & (US$ Million) Table 97. SAMEA Decitabine Drug Revenue by Application (2027-2032) & (US$ Million) Table 98. SAMEA Decitabine Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. SAMEA Decitabine Drug Revenue by Country (2021-2026) & (US$ Million) Table 100. SAMEA Decitabine Drug Revenue by Country (US$ Million) & (2027-2032) Table 101. Research Programs/Design for This Report Table 102. Authors List of This Report Table 103. Secondary Sources Table 104. Primary Sources List of Figures Figure 1. Decitabine Drug Image Figure 2. Global Decitabine Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Decitabine Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Dacogen Image Figure 5. Generic Image Figure 6. Global Decitabine Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Decitabine Drug Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Drug store Image Figure 10. Global Decitabine Drug Market Size (US$ Million) & (2021-2032) Figure 11. Global Decitabine Drug Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Decitabine Drug Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Decitabine Drug Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Decitabine Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Decitabine Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Decitabine Drug Revenue Market Share by Type (2021-2032) Figure 18. Global Decitabine Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Decitabine Drug Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Decitabine Drug Revenue Market Share by Application (2021-2032) Figure 21. North America Decitabine Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Decitabine Drug Revenue Share by Type (2021-2032) Figure 23. North America Decitabine Drug Revenue Share by Application (2021-2032) Figure 24. North America Decitabine Drug Revenue Share by Country (2021-2032) Figure 25. United States Decitabine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Decitabine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Decitabine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Decitabine Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Decitabine Drug Revenue Share by Type (2021-2032) Figure 30. Europe Decitabine Drug Revenue Share by Application (2021-2032) Figure 31. Europe Decitabine Drug Revenue Share by Country (2021-2032) Figure 32. Germany Decitabine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Decitabine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Decitabine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Decitabine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Decitabine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Decitabine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Decitabine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Decitabine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Decitabine Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Decitabine Drug Revenue Share by Type (2021-2032) Figure 42. China Decitabine Drug Revenue Share by Application (2021-2032) Figure 43. Asia Decitabine Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Decitabine Drug Revenue Share by Type (2021-2032) Figure 45. Asia Decitabine Drug Revenue Share by Application (2021-2032) Figure 46. Asia Decitabine Drug Revenue Share by Region (2021-2032) Figure 47. Japan Decitabine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Decitabine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Decitabine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Decitabine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Decitabine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Decitabine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Decitabine Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Decitabine Drug Revenue Share by Type (2021-2032) Figure 55. SAMEA Decitabine Drug Revenue Share by Application (2021-2032) Figure 56. SAMEA Decitabine Drug Revenue Share by Country (2021-2032) Figure 57. Brazil Decitabine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Decitabine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Decitabine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Decitabine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Decitabine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Decitabine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Decitabine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Decitabine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Decitabine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Decitabine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Decitabine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Dacogen
  • Generic
Applications
  • Hospital
  • Drug store
Companies covered
  • Sun Pharmaceutical
  • Sandoz
  • Otsuka Pharmaceutical
  • Lupin
  • Dr Reddy's Laboratories
  • Cipla
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Decitabine Drug Market by Type
  3. 1.2.1 Global Decitabine Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Dacogen
  5. 1.2.3 Generic
  6. 1.3 Decitabine Drug Market by Application
  7. 1.3.1 Global Decitabine Drug Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Drug store
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Decitabine Drug Market Dynamics
  1. 2.1 Decitabine Drug Industry Trends
  2. 2.2 Decitabine Drug Industry Drivers
  3. 2.3 Decitabine Drug Industry Opportunities and Challenges
  4. 2.4 Decitabine Drug Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Decitabine Drug Market Perspective (2021-2032)
  2. 3.2 Global Decitabine Drug Growth Trends by Region
  3. 3.2.1 Global Decitabine Drug Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Decitabine Drug Market Size by Region (2021-2026)
  5. 3.2.3 Global Decitabine Drug Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Decitabine Drug Revenue by Players
  2. 4.1.1 Global Decitabine Drug Revenue by Players (2021-2026)
  3. 4.1.2 Global Decitabine Drug Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Decitabine Drug Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Decitabine Drug Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Decitabine Drug Key Players Headquarters & Area Served
  7. 4.4 Global Decitabine Drug Players, Product Type & Application
  8. 4.5 Global Decitabine Drug Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Decitabine Drug Market CR5 and HHI
  11. 4.6.3 2025 Decitabine Drug Tier 1, Tier 2, and Tier 3
5 Decitabine Drug Market Size by Type
  1. 5.1 Global Decitabine Drug Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Decitabine Drug Revenue by Type (2021-2032)
  3. 5.3 Global Decitabine Drug Revenue Market Share by Type (2021-2032)
6 Decitabine Drug Market Size by Application
  1. 6.1 Global Decitabine Drug Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Decitabine Drug Revenue by Application (2021-2032)
  3. 6.3 Global Decitabine Drug Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Sun Pharmaceutical
  2. 7.1.1 Sun Pharmaceutical Company Information
  3. 7.1.2 Sun Pharmaceutical Business Overview
  4. 7.1.3 Sun Pharmaceutical Decitabine Drug Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Sun Pharmaceutical Decitabine Drug Product Portfolio
  6. 7.1.5 Sun Pharmaceutical Recent Developments
  7. 7.2 Sandoz
  8. 7.2.1 Sandoz Company Information
  9. 7.2.2 Sandoz Business Overview
  10. 7.2.3 Sandoz Decitabine Drug Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Sandoz Decitabine Drug Product Portfolio
  12. 7.2.5 Sandoz Recent Developments
  13. 7.3 Otsuka Pharmaceutical
  14. 7.3.1 Otsuka Pharmaceutical Company Information
  15. 7.3.2 Otsuka Pharmaceutical Business Overview
  16. 7.3.3 Otsuka Pharmaceutical Decitabine Drug Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Otsuka Pharmaceutical Decitabine Drug Product Portfolio
  18. 7.3.5 Otsuka Pharmaceutical Recent Developments
  19. 7.4 Lupin
  20. 7.4.1 Lupin Company Information
  21. 7.4.2 Lupin Business Overview
  22. 7.4.3 Lupin Decitabine Drug Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Lupin Decitabine Drug Product Portfolio
  24. 7.4.5 Lupin Recent Developments
  25. 7.5 Dr Reddy's Laboratories
  26. 7.5.1 Dr Reddy's Laboratories Company Information
  27. 7.5.2 Dr Reddy's Laboratories Business Overview
  28. 7.5.3 Dr Reddy's Laboratories Decitabine Drug Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Dr Reddy's Laboratories Decitabine Drug Product Portfolio
  30. 7.5.5 Dr Reddy's Laboratories Recent Developments
  31. 7.6 Cipla
  32. 7.6.1 Cipla Company Information
  33. 7.6.2 Cipla Business Overview
  34. 7.6.3 Cipla Decitabine Drug Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Cipla Decitabine Drug Product Portfolio
  36. 7.6.5 Cipla Recent Developments
  37. 7.7 Accord Healthcare
  38. 7.7.1 Accord Healthcare Company Information
  39. 7.7.2 Accord Healthcare Business Overview
  40. 7.7.3 Accord Healthcare Decitabine Drug Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Accord Healthcare Decitabine Drug Product Portfolio
  42. 7.7.5 Accord Healthcare Recent Developments
8 North America
  1. 8.1 North America Decitabine Drug Revenue (2021-2032)
  2. 8.2 North America Decitabine Drug Revenue by Type (2021-2032)
  3. 8.2.1 North America Decitabine Drug Revenue by Type (2021-2026)
  4. 8.2.2 North America Decitabine Drug Revenue by Type (2027-2032)
  5. 8.3 North America Decitabine Drug Revenue Share by Type (2021-2032)
  6. 8.4 North America Decitabine Drug Revenue by Application (2021-2032)
  7. 8.4.1 North America Decitabine Drug Revenue by Application (2021-2026)
  8. 8.4.2 North America Decitabine Drug Revenue by Application (2027-2032)
  9. 8.5 North America Decitabine Drug Revenue Share by Application (2021-2032)
  10. 8.6 North America Decitabine Drug Revenue by Country
  11. 8.6.1 North America Decitabine Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Decitabine Drug Revenue by Country (2021-2026)
  13. 8.6.3 North America Decitabine Drug Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Decitabine Drug Revenue (2021-2032)
  2. 9.2 Europe Decitabine Drug Revenue by Type (2021-2032)
  3. 9.2.1 Europe Decitabine Drug Revenue by Type (2021-2026)
  4. 9.2.2 Europe Decitabine Drug Revenue by Type (2027-2032)
  5. 9.3 Europe Decitabine Drug Revenue Share by Type (2021-2032)
  6. 9.4 Europe Decitabine Drug Revenue by Application (2021-2032)
  7. 9.4.1 Europe Decitabine Drug Revenue by Application (2021-2026)
  8. 9.4.2 Europe Decitabine Drug Revenue by Application (2027-2032)
  9. 9.5 Europe Decitabine Drug Revenue Share by Application (2021-2032)
  10. 9.6 Europe Decitabine Drug Revenue by Country
  11. 9.6.1 Europe Decitabine Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Decitabine Drug Revenue by Country (2021-2026)
  13. 9.6.3 Europe Decitabine Drug Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Decitabine Drug Revenue (2021-2032)
  2. 10.2 China Decitabine Drug Revenue by Type (2021-2032)
  3. 10.2.1 China Decitabine Drug Revenue by Type (2021-2026)
  4. 10.2.2 China Decitabine Drug Revenue by Type (2027-2032)
  5. 10.3 China Decitabine Drug Revenue Share by Type (2021-2032)
  6. 10.4 China Decitabine Drug Revenue by Application (2021-2032)
  7. 10.4.1 China Decitabine Drug Revenue by Application (2021-2026)
  8. 10.4.2 China Decitabine Drug Revenue by Application (2027-2032)
  9. 10.5 China Decitabine Drug Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Decitabine Drug Revenue (2021-2032)
  2. 11.2 Asia Decitabine Drug Revenue by Type (2021-2032)
  3. 11.2.1 Asia Decitabine Drug Revenue by Type (2021-2026)
  4. 11.2.2 Asia Decitabine Drug Revenue by Type (2027-2032)
  5. 11.3 Asia Decitabine Drug Revenue Share by Type (2021-2032)
  6. 11.4 Asia Decitabine Drug Revenue by Application (2021-2032)
  7. 11.4.1 Asia Decitabine Drug Revenue by Application (2021-2026)
  8. 11.4.2 Asia Decitabine Drug Revenue by Application (2027-2032)
  9. 11.5 Asia Decitabine Drug Revenue Share by Application (2021-2032)
  10. 11.6 Asia Decitabine Drug Revenue by Country
  11. 11.6.1 Asia Decitabine Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Decitabine Drug Revenue by Country (2021-2026)
  13. 11.6.3 Asia Decitabine Drug Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Decitabine Drug Revenue (2021-2032)
  2. 12.2 SAMEA Decitabine Drug Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Decitabine Drug Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Decitabine Drug Revenue by Type (2027-2032)
  5. 12.3 SAMEA Decitabine Drug Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Decitabine Drug Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Decitabine Drug Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Decitabine Drug Revenue by Application (2027-2032)
  9. 12.5 SAMEA Decitabine Drug Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Decitabine Drug Revenue by Country
  11. 12.6.1 SAMEA Decitabine Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Decitabine Drug Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Decitabine Drug Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst